Article
Genetic determinants of multiple myeloma risk within the Wnt/beta-catenin signaling pathway.
Cancer epidemiology - 1 Aug 2021
Belachew Alem A, Wu Xifeng, Callender Rashida, Waller Rosalie, Orlowski Robert Z, Vachon Celine M, Camp Nicola J, Ziv Elad, Hildebrandt Michelle A T
Abstract excerpt
BACKGROUND: Aberrant Wnt/beta-catenin pathway activation is implicated in Multiple Myeloma (MM) development, but little is known if genetic variants within this pathway contribute to MM susceptibility. METHODS: We performed a discovery candidate pathway analysis in 269 non-Hispanic white MM cases and 272 controls focusing on 171 variants selected from 26 core genes within the Wnt/beta-catenin pathway. Significant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
